| 发明名称 |
EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN |
| 摘要 |
The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain. The invention relates in more detail to compositions comprising inhibitors of EGFR |
| 申请公布号 |
WO2014095088(A1) |
申请公布日期 |
2014.06.26 |
| 申请号 |
WO2013EP03931 |
申请日期 |
2013.12.20 |
| 申请人 |
SYKEHUSET SØRLANDET HF |
发明人 |
KERSTEN, CHRISTIAN;CAMERON, MARTE GRØNLIE;MJ&angst,LAND, SVEIN |
| 分类号 |
C07K16/28;A61K31/517;A61K31/5377;A61K39/395;A61K45/06;A61P25/00;A61P25/02 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
